2025-07-22 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive Co (CL) based on the data you've provided, formatted as requested:

## Colgate-Palmolive Co (CL) Stock Analysis

### 1. Performance vs. S&P 500 (VOO)

*   **Ticker:** CL
*   **Company:** Colgate-Palmolive Co
*   **Description:** Colgate-Palmolive is a global consumer products company focused on the production, distribution, and provision of household, health care, and personal care products.

**Key Metrics:**

*   **CL Cumulative Return:** 13.96%
*   **VOO Cumulative Return:** 97.07%
*   **Absolute Divergence:** -82.7 (CL is underperforming VOO)
*   **Divergence Range:** Max: 7.9, Min: -82.8
*   **Relative Divergence:** 0.1 (CL is near its historical low relative to VOO)

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD      | Alpha   | Beta   | Cap(B) |
|------------|---------|----------|---------|--------|--------|
| 2015-2017  | 13.0%   | 4.5%     | -16.0%  | 0.0    | 61.1   |
| 2016-2018  | -11.0%  | 65.2%    | -29.0%  | 0.1    | 48.2   |
| 2017-2019  | 7.0%    | 65.2%    | -22.0%  | 0.1    | 55.8   |
| 2018-2020  | 18.0%   | 65.2%    | -2.0%   | 0.6    | 69.3   |
| 2019-2021  | 30.0%   | 58.6%    | -19.0%  | 0.7    | 69.2   |
| 2020-2022  | 7.0%    | 69.0%    | 5.0%    | 0.7    | 63.9   |
| 2021-2023  | 6.0%    | 69.0%    | -12.0%  | 0.8    | 64.6   |
| 2022-2024  | 13.0%   | 69.0%    | -12.0%  | 0.8    | 73.7   |
| 2023-2025  | 1.0%    | 70.6%    | -48.0%  | 0.3    | 70.2   |

**Analysis:**

*   **Underperformance:** CL has significantly underperformed the S&P 500 (VOO) over the period analyzed. The cumulative return difference is substantial.
*   **Relative Weakness:**  The relative divergence indicates that CL's underperformance is near its historical worst compared to VOO.
*   **Alpha & Beta:** The negative alpha values indicate that CL has consistently underperformed relative to what its beta would predict based on market movements. The beta values themselves are generally low, suggesting that CL's price is not highly correlated with the overall market. The recent period (2023-2025) shows a particularly large negative alpha.
*   **CAGR & MDD:** CAGR is inconsistent, while MDD has been high

### 2. Recent Price Action

*   **Current Price:** 86.64
*   **Previous Close:** 86.84
*   **Change:** -0.23
*   **5-day Moving Average:** 87.262
*   **20-day Moving Average:** 89.586
*   **60-day Moving Average:** 90.4697

**Analysis:**

*   The stock price is currently below all three moving averages (5, 20, and 60-day), suggesting a downward trend in the short to medium term. The small negative `change` from the `previousClose` indicates a minor, recent price decrease.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3383 (Low Risk)
*   **RSI:** 26.74 (Oversold)
*   **PPO:** -0.5162
*   **Hybrid Signal:** cash_70%_Sell 69.9% of holdings (1169 shares - Caution - MRI:0.34) (Cash Ratio: 70% on 2025-07-16)
*   **Recent (20-day) Relative Divergence Change:** 0.1 (+) 단기상승
*   **Expected Return:** -3599.3%

**Analysis:**

*   **MRI:** The MRI indicates a low-risk environment.
*   **RSI:** The RSI is in oversold territory, which *could* suggest a potential for a price rebound. However, it can also remain oversold for extended periods during a strong downtrend.
*   **PPO:** The negative PPO value indicates that the short-term moving average is below the long-term moving average, reinforcing the downtrend signal.
*   **Hybrid Signal:** The hybrid signal is highly bearish, recommending a significant reduction in holdings and a high cash position.
*   **Recent Divergence Change:** The slight positive change in relative divergence suggests a potential short-term upward movement, but this is occurring within a larger context of underperformance.
*   **Expected Return:** The extremely negative expected return is highly concerning and suggests that the model predicts significant underperformance relative to the S&P 500 over the long term.

### 4. Recent News & Significant Events

*   **[2025-07-22]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-20]:** Analyst discussions about performance and outlook in the context of industry and global economics.
*   **[2025-07-19]:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-07-21]:** Market experts highlighting both risks and opportunities.

**Analysis:**

*   The news snippets suggest a dynamic situation with potential challenges and opportunities for Colgate-Palmolive. The volatility mentioned in one headline aligns with the recent price action.  Need to investigate specific details of news and events.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-04-25 | 0.85  | 4.91 B$    |
| 2024-10-25 | 0.9   | 5.03 B$    |
| 2024-07-26 | 0.89  | 5.06 B$    |
| 2024-04-26 | 0.83  | 5.07 B$    |
| 2025-04-25 | 0.83  | 5.07 B$    |

**Analysis:**

*   **Revenue Trend:** Revenue shows a slight downward trend in the most recent quarters.
*   **EPS Trend:** EPS has fluctuated. Most recent value are lower than recent history.
* The table includes duplicate data which is unusual.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $4.91B    | 60.82%        |
| 2024-12-31   | $4.95B    | 60.30%        |
| 2024-09-30   | $5.03B    | 61.08%        |
| 2024-06-30   | $5.06B    | 60.62%        |
| 2024-03-31   | $5.07B    | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE         |
|--------------|-----------|-------------|
| 2025-03-31   | $0.36B    | 190.08%     |
| 2024-12-31   | $0.21B    | 348.58%     |
| 2024-09-30   | $0.43B    | 169.43%     |
| 2024-06-30   | $0.12B    | 594.31%     |
| 2024-03-31   | $0.23B    | 296.96%     |

**Analysis:**

*   **Revenue and Profitability:** Revenue has been slightly decreasing over the past few quarters. Profit margins are relatively stable and high, indicating strong pricing power and cost management.
*   **Capital and Profitability:** Equity has fluctuated.  ROE is exceptionally high in all quarters, which is unusual and warrants further investigation. It's important to understand how ROE is calculated in this context and whether there are any accounting factors that might be distorting the figures.

### 7. Overall Assessment

Colgate-Palmolive (CL) presents a mixed picture based on the provided data.

**Key Concerns:**

*   **Significant Underperformance:** CL has significantly underperformed the S&P 500 (VOO) over the period analyzed.
*   **Negative Outlook:** The hybrid signal suggests strong selling pressure, and the expected return is very negative.
*   **Downward Trend:** The stock price is below its moving averages, indicating a downtrend.
*   **Declining Revenue:** Recent earnings and financial data show a slight downward trend in revenue.
*   **High MDD & Alpha:** High MDD & Alpha has been negative values.
*   **ROE:** Exceptionally high ROE needs further investigation

**Potential Positives:**

*   **Oversold Conditions:** The RSI indicates that the stock is oversold, which *could* lead to a short-term rebound.
*   **Low Risk (MRI):** The market risk indicator is low, suggesting a relatively stable environment.
*   **High Profit Margins:** The company maintains strong profit margins.
* **Recent Divergence Change:** The slight positive change in relative divergence suggests a potential short-term upward movement

**Recommendation:**

Based on this analysis, a cautious approach is warranted. The underperformance, negative outlook, and downward trend are significant concerns. Further research is needed to understand the specific reasons for the underperformance and the factors driving the negative outlook. The recent news events should be investigated in detail. It is difficult to recommend the stock at this time. Investors should consider the potential risks and conduct thorough due diligence before making any investment decisions.
